NCT07325864 Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
| NCT ID | NCT07325864 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Institute of Oncology |
| Condition | NSCLC |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-12-18 |
| Primary Completion | 2027-06-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
investigate the molecular differences between primitive lung cancer and the metastatic site.
Eligibility Criteria
Inclusion Criteria: * patients aged ≥18 years fit enough to tolerate the surgical operation; * the operative risk is considered low based on respiratory reserve and cardiac assessment; * the patient has clearly expressed willingness to adhere; * availability of pathological material for tumor DNA extraction and NGS execution. Exclusion Criteria: * Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study. * Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation. * Recent or ongoing severe or clinically significant infection.